HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Takaya Selected Research

Metalloproteases (Metalloproteinases)

5/2019ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma.
9/2017Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Takaya Research Topics

Disease

33Fibrosis (Cirrhosis)
01/2024 - 08/2017
32Liver Cirrhosis (Hepatic Cirrhosis)
01/2024 - 02/2011
14Hepatocellular Carcinoma (Hepatoma)
11/2022 - 08/2017
9Non-alcoholic Fatty Liver Disease
11/2023 - 02/2016
8Fatty Liver
10/2022 - 11/2017
8Neoplasms (Cancer)
01/2021 - 01/2015
6Sarcopenia
08/2023 - 01/2020
5Liver Diseases (Liver Disease)
05/2023 - 01/2019
5Ascites
05/2023 - 08/2017
5Hyperammonemia
08/2022 - 12/2017
5Hepatic Encephalopathy
12/2021 - 12/2017
4Alcoholic Liver Diseases (Alcoholic Liver Disease)
12/2021 - 01/2013
4Inflammation (Inflammations)
12/2021 - 01/2013
4Infections
06/2021 - 01/2018
3Autoimmune Hepatitis
07/2023 - 06/2021
3Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
06/2023 - 07/2021
3Acute-On-Chronic Liver Failure
01/2023 - 05/2020
3Alcoholic Fatty Liver
10/2022 - 06/2018
3Thrombophilia
03/2022 - 05/2019
3Dysbiosis
06/2021 - 01/2018
3Muscle Cramp (Cramp)
12/2020 - 01/2019
3Hemorrhage
09/2020 - 02/2011
3Thrombosis (Thrombus)
09/2020 - 02/2011
3Insulin Resistance
08/2020 - 09/2019
2Atrophy
08/2022 - 12/2021
2Cognitive Dysfunction
06/2021 - 03/2020
2Body Weight (Weight, Body)
01/2021 - 08/2017
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020 - 01/2019
2Thrombocytopenia (Thrombopenia)
09/2020 - 01/2020
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
07/2020 - 01/2017
2Hypertension (High Blood Pressure)
06/2020 - 11/2017
2Endotoxemia
03/2020 - 12/2017
2Carcinogenesis
03/2020 - 11/2017
2Chronic Hepatitis (Chronic Active Hepatitis)
01/2019 - 11/2018
2Hepatitis B
11/2018 - 08/2017
2Multiple Organ Failure (MODS)
02/2018 - 09/2017
2Hepatitis C
01/2018 - 08/2017
2Varicose Veins (Varicose Vein)
01/2018 - 02/2011
1Acute Kidney Injury (Acute Renal Failure)
01/2024
1COVID-19
11/2023

Drug/Important Bio-Agent (IBA)

15Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2018
14EndotoxinsIBA
06/2023 - 01/2013
10von Willebrand FactorIBA
01/2024 - 09/2017
7LipopolysaccharidesIBA
10/2022 - 08/2017
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2023 - 09/2017
6Rifaximin (L 105)FDA Link
10/2022 - 12/2017
6CytokinesIBA
08/2022 - 01/2013
6Angiotensin II Type 1 Receptor BlockersIBA
01/2022 - 02/2016
5ZincIBA
07/2023 - 06/2021
5AntigensIBA
01/2023 - 09/2017
5Amino AcidsFDA Link
10/2022 - 10/2016
4Toll-Like Receptor 4IBA
10/2022 - 06/2021
4Choline (Choline Chloride)IBA
10/2022 - 10/2016
4Losartan (Cozaar)FDA LinkGeneric
01/2022 - 11/2017
4DiureticsIBA
01/2021 - 08/2017
3lenvatinibIBA
10/2022 - 01/2021
3CDAA (Randox)IBA
10/2022 - 10/2016
3AlbuminsIBA
10/2022 - 09/2019
3TolvaptanFDA Link
05/2022 - 08/2017
3Carbon Tetrachloride (Tetrachloromethane)IBA
12/2021 - 01/2021
3Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 03/2020
3Angiotensin Receptor AntagonistsIBA
12/2021 - 08/2020
3Tissue Inhibitor of MetalloproteinasesIBA
10/2021 - 08/2020
3Hyaluronic Acid (Hyaluronan)IBA
10/2021 - 08/2020
3Carrier Proteins (Binding Protein)IBA
10/2021 - 08/2020
3AntioxidantsIBA
06/2021 - 12/2020
3CollagenIBA
10/2020 - 08/2020
3Antiviral Agents (Antivirals)IBA
08/2020 - 01/2018
3Ursodeoxycholic Acid (Urso)FDA LinkGeneric
07/2020 - 02/2016
3Glucose (Dextrose)FDA LinkGeneric
03/2020 - 11/2017
2Urea (Carbamide)FDA LinkGeneric
11/2023 - 08/2017
2NitrogenIBA
11/2023 - 08/2017
2Hemoglobins (Hemoglobin)IBA
08/2023 - 06/2023
2BilirubinIBA
10/2022 - 10/2021
2MyostatinIBA
08/2022 - 03/2022
2EnzymesIBA
04/2022 - 06/2021
2AmmoniaIBA
03/2022 - 03/2020
2Ethanol (Ethyl Alcohol)IBA
12/2021 - 01/2021
2Branched-Chain Amino AcidsIBA
12/2021 - 09/2019
2Collagen Type III (Type III Collagen)IBA
10/2021 - 08/2020
2Triglycerides (Triacylglycerol)IBA
09/2021 - 06/2020
2Interleukin-8 (Interleukin 8)IBA
06/2021 - 09/2017
2InterleukinsIBA
06/2021 - 09/2017
2Carnitine (L-Carnitine)FDA LinkGeneric
12/2020 - 01/2019
2procollagen Type III-N-terminal peptide (PIIP)IBA
10/2020 - 08/2020
2lusutrombopagIBA
09/2020 - 01/2020
2Bile Acids and Salts (Bile Acids)IBA
06/2020 - 11/2017
2Alanine Transaminase (SGPT)IBA
04/2020 - 09/2017
2Insulin (Novolin)FDA Link
04/2020 - 09/2019
2Sorafenib (BAY 43-9006)FDA Link
12/2019 - 05/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019 - 05/2019
2ThrombospondinsIBA
05/2019 - 09/2017
2Metalloproteases (Metalloproteinases)IBA
05/2019 - 09/2017
2Toll-Like Receptors (Toll-Like Receptor)IBA
03/2019 - 01/2013
2Dipeptidyl-Peptidase IV InhibitorsIBA
01/2019 - 11/2017

Therapy/Procedure

13Therapeutics
05/2023 - 02/2011
5Oral Administration
10/2022 - 01/2018
5Drug Therapy (Chemotherapy)
12/2020 - 01/2015
3Intraperitoneal Injections
01/2021 - 01/2019
2Liver Transplantation
06/2021 - 01/2018